WASHINGTON (Reuters) - Hormone replacement therapy, which raises breast cancer risk for some women, appears to reduce the risk for those with a certain genetic mutation linked to the disease, researchers said on Tuesday.
WASHINGTON (Reuters) - Hormone replacement therapy, which raises breast cancer risk for some women, appears to reduce the risk for those with a certain genetic mutation linked to the disease, researchers said on Tuesday.